Form 8-K - Current report:
SEC Accession No. 0001493152-25-007942
Filing Date
2025-02-24
Accepted
2025-02-21 18:20:07
Documents
14
Period of Report
2025-02-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 63180
  Complete submission text file 0001493152-25-007942.txt   280725

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ptix-20250221.xsd EX-101.SCH 3516
3 XBRL DEFINITION FILE ptix-20250221_def.xml EX-101.DEF 26547
4 XBRL LABEL FILE ptix-20250221_lab.xml EX-101.LAB 36501
5 XBRL PRESENTATION FILE ptix-20250221_pre.xml EX-101.PRE 25171
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5459
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12555 | Film No.: 25653588
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)